The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation

These results suggest that sitagliptin is able to positively modulate vascular EC function under conditions of retinal inflammation.